Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trialCLARITY is a ...
Aclarion announces revised reverse stock split details
BROOMFIELD, CO - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company with a current market capitalization of ...
Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference
We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...
Becker's Spine Review10h
Northwestern Medicine joins Aclarion's spine clinical trial
Chicago-based Northwestern Medicine will be the first site for Clarion's Clarity trial for spine surgery, according to a Feb. 6 news release.
Aclarion secures funding for pivotal CLARITY trial
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company, announced today that it has raised nearly $20 million in gross proceeds since January 1, 2025. This funding ...
1ACON : What's Going On With Aclarion Stock Tuesday?
Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...
Nasdaq13d
Aclarion Announces Reverse Stock Split
BROOMFIELD, CO - January 24, 2025 (NEWMEDIAWIRE) - Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is ...